Vivani Medical | Mergers and Acquisitions Presentation Deck | 27 slides

Vivani Medical · 2022-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

27
every slide · same image gating as the playbook
01
Slide 1
The slide indicates a corporate merger or combination.front_matter
04
summarize
05
The slide uses a table-like structure to represent a product development roadmap.plan_implementation
06
transition
07
The slide uses a combination of text-based value propositions and technical illustrations of the device components (Drug Reservoir and Nanotube Membrane).present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
08
Uses a visual comparison of three pore sizes to illustrate the concept of controlled release.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
09
present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
10
transition
11
present_solution
12
The chart highlights the projected market size of ~$23B by 2026.size_opportunity
Open slide detailBeat · Market Size
13
The chart compares real-world adherence of existing drugs (Januvia, Trulicity, Invokana) against the theoretical 100% adherence of the investigational NPM-119 iframe_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
14
The slide uses a table to compare existing GLP-1 products with different administration methods, positioning the investigational candidate NPM-119 as a solutionpresent_solution
Open slide detailLoop · Cost Of Inaction
15
The slide uses a timeline-like structure to show both the commercial validation (deal size/valuation) and the regulatory hurdles (CRL) faced by the analog producite_precedent
16
compare_peers
Open slide detailBeat · Competition
17
The chart includes dual y-axes for rat and human equivalent concentrations and indicates the point of implant removal.show_traction
18
transition
19
The slide outlines a randomized clinical trial structure with three arms of 20 patients each.plan_implementation
20
The slide uses a table to present a roadmap and bullet points to detail progress.plan_implementation
21
front_matter
22
plan_implementation
23
transition
Open slide detailBeat · Financials
24
Includes historical data for Second Sight and NPM, pro forma adjustments, and combined totals.analyze_data
Open slide detailBeat · Financials
25
Financial table showing assets, liabilities, and equity adjustments for a merger.analyze_data
Open slide detailBeat · Financials
26
Includes footnotes regarding unvested options and underwater warrants.analyze_data
Open slide detailBeat · Financials
27
summarize